April Bordges
Medical · Medford, NYNPI 1497082085
Payments from drug & device makers
Across 676 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Ardelyx, Inc.$611
- Takeda Pharmaceuticals U.S.A., Inc.$578
- Nestle Healthcare Nutrition Inc.$453
- Ironwood Pharmaceuticals, Inc$383
- plus $4K from 26 others
What the payments were for
- Food & beverage$11,123100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 221 | $3,130 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 169 | $2,365 |
| Ardelyx, Inc. | 30 | $611 |
| Takeda Pharmaceuticals U.S.A., Inc. | 28 | $578 |
| Nestle Healthcare Nutrition Inc. | 19 | $453 |
| Ironwood Pharmaceuticals, Inc | 17 | $383 |
| Sanofi | 16 | $380 |
| Phathom Pharmaceuticals, Inc. | 27 | $342 |
| Johnson & Johnson | 17 | $283 |
| Redhill Biopharma Inc. | 15 | $264 |
| Bristol Myers Squibb | 15 | $253 |
| Madrigal Pharmaceuticals | 9 | $245 |
| Intercept Pharmaceuticals, Inc. | 11 | $211 |
| Daiichi Sankyo Inc. | 9 | $209 |
| Gilead | 13 | $208 |
| Pfizer | 13 | $206 |
| Braintree Laboratories, Inc. | 6 | $159 |
| Merck | 8 | $154 |
| Ferring Pharmaceuticals Inc. | 7 | $133 |
| Regeneron Healthcare Solutions, Inc. | 7 | $121 |
| Evoke Pharma, Inc. | 6 | $116 |
| Boehringer Ingelheim | 3 | $61 |
| Endogastric Solutions, Inc | 1 | $55 |
| Celltrion USA Inc. | 1 | $40 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| QOL Medical, LLC | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Axonics, Inc. | 1 | $21 |
| Exact Sciences | 1 | $19 |
| Sandoz | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$11,123 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 100 | $108,875 |
| Mesalamine | 12 | $22,459 |
| LyricaPregabalin | 13 | $13,452 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 214 | $12,117 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 37 | $6,275 |
| Dexlansoprazole DrDexlansoprazole | 17 | $4,151 |
| Esomeprazole Magnesium | 11 | $3,511 |
| Lubiprostone | 30 | $3,317 |
| Pantoprazole Sodium | 350 | $3,231 |
| Sucralfate | 12 | $2,880 |
| Omeprazole | 181 | $2,171 |
| Ondansetron OdtOndansetron | 20 | $2,129 |
| Dicyclomine Hcl | 71 | $2,062 |
| Famotidine | 103 | $1,701 |
| Alprazolam | 41 | $657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $3,130 | $108,875100 claims |
| PfizerLyrica | $206 | $13,45213 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $133 | $6,27537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.
Other medical in Medford
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.